|
|
| Outsourcing the development and manufacture of your novel therapeutic demands advanced consideration to ensure the timely and cost-effective completion of your project. Outsourced Pharma is helping address these difficulties. The Outsourced Pharma Capacity Update (OPCU), a free interactive digital event, convenes the industry's foremost CDMOs to provide up-to-date and direct insights into their available capacity and services, alongside specific facility and equipment updates. Discover the July 2024 event’s presenting sponsors in this newsletter and learn how they are best suited to help you to navigate the path to approval and commercialization. These short, digestible presentations give you an inside look at the available capacity of industry suppliers, all from the comfort of your desk. And we've expanded! Our PARTNER WEEK format offers an extended schedule and sessions grouped by capability for an ultra-convenient way to see partner capacities related to your specific outsourcing requirements. Find the right development and manufacturing partner at the upcoming OPCU in October 2024. Registration is free at the links below. - Monday, October 21, 2024 - ADC
- Tuesday, October 22, 2024 - Large Molecule Drug Substance
- Wednesday, October 23, 2024 - Small Molecule
- Thursday, October 24, 2024 - Cell & Gene Therapy
- Friday, October 25, 2024 - Fill/Finish
|
|
|
|
Mycenax | Our capabilities include filling vials (liquid or lyophilized), pre-filled syringes (PFS), and cartridge product types, supporting batch sizes of 1,000 to 100,000 vials and up to 120 batches annually. | Request Information | Mycenax |
|
|
Mabion | Mabion, a biologics CDMO with end-to-end services focusing on recombinant proteins, showcases new depyrogenation, fill finish vial capabilities, and CMC analytical proficiencies. | Request Information | Mabion |
|
|
|
Singota Solutions | Review services including formulation development, analytical testing, aseptic filling, and supply chain management, as well as our commitment to do things right the first time. | Request Information | Singota Solutions |
|
|
Simtra BioPharma Solutions | We currently have open capacity for development services as well as liquid vial projects at both manufacturing sites and can support rapid tech transfer depending on the complexity of the project. | Request Information | Simtra BioPharma Solutions |
|
|
Ajinomoto Bio-Pharma Services | Review our range of offerings including our high speed, multi-purpose fill finish line for vials, syringes, and cartridges located in our manufacturing facilities in San Diego, CA. | Request Information | Ajinomoto Bio-Pharma Services |
|
|
LARGE MOLECULE DRUG SUBSTANCE & DEVELOPMENT |
|
|
Curia | Curia Biologics can be a critical partner for small, midsize, and even large biotech businesses to support all requirements from IND through late stage commercial programs. | Request Information | Curia |
|
|
Scorpius Biomanufacturing | VP of Manufacturing Operations Matt LeClair presents a 3D virtual tour of the process development lab, analytical and QC lab, and the mammalian manufacturing upstream and cell culture suites. | Request Information | Scorpius BioManufacturing |
|
|
AbbVie | Delve into the intricacies of biopharmaceutical manufacturing, focusing on stages such as CLD, fermentation, and purification. We also explore process optimization and scale-up techniques. | Request Information | AbbVie |
|
|
Novartis | Review our capabilities in tech transfer, clinical drug substance, and commercial drug substance manufacturing across our manufacturing network in Singapore, Europe, and the US. | Request Information | Novartis Contract Manufacturing |
|
|
Aton Biotech | We explain how unifying key functions, experience, and broad capabilities can accelerate more pipelines to market. Gain insights into boosting efficiency, fostering innovation, and how integrated capabilities generate value for innovators. | Request Information | Aton Biotech |
|
|
Mabion | Explore our new installations in upstream development and fill-finish. This state of the art EU-GMP facility is staffed by a team of 250 professionals, and capacity is now available. | Request Information | Mabion |
|
|
|
|
| Streamline your search for the ideal CDMO partner at the October 2024 OPCU virtual event! Ease the burden of a prolonged vetting process and connect with multiple CDMOs in a single day to find the partner best suited for your project. Register here for the virtual event! For your convenience, OPCU is grouped by capability type. You can register for the session(s) highlighting the CDMOs equipped to meet your company's development and manufacturing needs. - Monday, October 21, 2024 - ADC | Free Registration
- Tuesday, October 22, 2024 - Large Molecule Drug Substance | Free Registration
- Wednesday, October 23, 2024 - Small Molecule | Free Registration
- Thursday, October 24, 2024 - Cell & Gene Therapy | Free Registration
- Friday, October 25, 2024 - Fil/Finish | Free Registration
|
|
|
